| Liquid filled nanoparticles as a drug delivery tool for protein therapeutics N Venkatesan, J Yoshimitsu, Y Ito, N Shibata, K Takada Biomaterials 26 (34), 7154-7163, 2005 | 310 | 2005 |
| Discoidal niosome based controlled ocular delivery of timolol maleate. SP Vyas, N Mysore, V Jaitely, N Venkatesan Die Pharmazie 53 (7), 466-469, 1998 | 128 | 1998 |
| Polysaccharide coated liposomes for oral immunization—development and characterization N Venkatesan, SP Vyas International journal of pharmaceutics 203 (1-2), 169-177, 2000 | 96 | 2000 |
| Gastro-intestinal patch system for the delivery of erythropoietin N Venkatesan, K Uchino, K Amagase, Y Ito, N Shibata, K Takada Journal of controlled release 111 (1-2), 19-26, 2006 | 82 | 2006 |
| Pelleted bioadhesive polymeric nanoparticles for buccal delivery of insulin: preparation and characterization P Venueopnrnru, A Snpnr, N Venxnresnru, SP Vyns Pharmazie 56, 217-219, 2001 | 72 | 2001 |
| Resealed erythrocytes: drug carrier potentials and biomedical applications V Jaitely, P Kanaujia, N Venkatesan, S Jain, SP Vyas Indian Drugs 33 (12), 589-594, 1996 | 71 | 1996 |
| Evaluation of vancomycin exposures associated with elevations in novel urinary biomarkers of acute kidney injury in vancomycin-treated rats NJ Rhodes, WC Prozialeck, TP Lodise, N Venkatesan, JN O'Donnell, ... Antimicrobial agents and chemotherapy 60 (10), 5742-5751, 2016 | 62 | 2016 |
| Proliposomes for oral delivery: progress and challenges V Nekkanti, N Venkatesan, G V Betageri Current pharmaceutical biotechnology 16 (4), 303-312, 2015 | 59 | 2015 |
| Pharmacokinetic and pharmacodynamic studies following oral administration of erythropoietin mucoadhesive tablets to beagle dogs N Venkatesan, J Yoshimitsu, Y Ohashi, Y Ito, N Sugioka, N Shibata, ... International journal of pharmaceutics 310 (1-2), 46-52, 2006 | 56 | 2006 |
| 24-hour pharmacokinetic relationships for vancomycin and novel urinary biomarkers of acute kidney injury JN O'Donnell, NJ Rhodes, TP Lodise, WC Prozialeck, CM Miglis, ... Antimicrobial agents and chemotherapy 61 (11), 10.1128/aac. 00416-17, 2017 | 48 | 2017 |
| Proliposomes as a drug delivery system to decrease the hepatic first-pass metabolism: case study using a model drug S Yanamandra, N Venkatesan, VG Kadajji, Z Wang, M Issar, GV Betageri European journal of pharmaceutical sciences 64, 26-36, 2014 | 42 | 2014 |
| Effect of fiber length of carbon nanotubes on the absorption of erythropoietin from rat small intestine Y Ito, N Venkatesan, N Hirako, N Sugioka, K Takada International journal of pharmaceutics 337 (1-2), 357-360, 2007 | 36 | 2007 |
| Improved oral bioavailability of valsartan using proliposomes: design, characterization and in vivo pharmacokinetics V Nekkanti, N Venkatesan, Z Wang, GV Betageri Drug development and industrial pharmacy 41 (12), 2077-2088, 2015 | 31 | 2015 |
| A single acting syringe pump based on Raspberry Pi-SOC K Akash, MP Kumar, N Venkatesan, M Venkatesan 2015 IEEE International Conference on Computational Intelligence and …, 2015 | 28 | 2015 |
| Liposomes as nanocarriers for anti-HIV therapy S Chopra, N Venkatesan, GV Betageri Drug delivery and translational research 3, 471-478, 2013 | 25 | 2013 |
| Formulation of lipid bearing pellets as a delivery system for poorly soluble drugs S Chopra, N Venkatesan, GV Betageri International journal of pharmaceutics 446 (1-2), 136-144, 2013 | 24 | 2013 |
| Protected particulate drug carriers for prolonged systemic circulation-a review N Venkatesan, BS Babu, S Sankar, SP Vyas Indian Journal of Pharmaceutical Sciences 62 (5), 327-333, 2000 | 23 | 2000 |
| Pharmaceutical development of solid dispersion based osmotic drug delivery system for nifedipine P Kanagale, V Patel, N Venkatesan, M Jain, P Patel, A Misra Current Drug Delivery 5 (4), 306-311, 2008 | 22 | 2008 |
| Physical compatibility of vancomycin and piperacillin sodium–tazobactam at concentrations typically used during prolonged infusions E Leung, N Venkatesan, SC Ly, MH Scheetz American journal of health-system pharmacy 70 (13), 1163-1166, 2013 | 20 | 2013 |
| Gelucire® 44/14 and Labrasol® in enhancing oral absorption of poorly absorbable drugs N Venkatesan, K Takada Influence of Lipid Excipients on Oral Drug Absorption, 200679, 2006 | 18 | 2006 |
Marc H. ScheetzProfessor of Pharmacy and Pharmacology, Midwestern University, Colleges of Pharmacy and GraduateVerified email at midwestern.edu
